Skip to main content

Table 1 ROTEM and FOR variables for enoxaparin and tinzaparin

From: Monitoring of treatment with low molecular weight heparins using viscoelastic devices

  

Enoxaparin

Tinzaparin

 

0 IU/ml

0.5 IU/ml

1.0 IU/ml

1.5 IU/ml

0.5 IU/ml

1.0 IU/ml

1.5 IU/ml

ROTEM

       

   CT (seconds)

175 ± 38

191 ± 89*

214 ± 109

249 ± 94*

223 ± 53*

289 ± 84*

326 ± 125*

   CFT (seconds)

77 ± 23

87 ± 21

85 ± 16

83 ± 22

74 ± 27

84 ± 45

80 ± 21

   Angle (°)

75 ± 4

74 ± 4

75 ± 3

74 ± 4

75 ± 5

73 ± 5

73 ± 4

   MCF (mm)

62 ± 5

61 ± 7

63 ± 5

63 ± 6

68 ± 7*

64 ± 8

65 ± 6*

   MCL (%)

8 ± 4

6 ± 3+

5 ± 4

2 ± 5*

5 ± 4*

6 ± 4

2 ± 4*

ReoRox

       

   COT1 (seconds)

30 ± 5

35 ± 7*

39 ± 8*

38 ± 11*

36 ± 4*

45 ± 9*

48 ± 15*

   COT2 (seconds)

65 ± 11

76 ± 13*

82 ± 14*

85 ± 20*

74 ± 5*

91 ± 16*

108 ± 29*

   COT2 - COT1 (seconds)

34 ± 10

41 ± 8*

43 ± 9*

46 ± 10*

37 ± 4

46 ± 11*

51 ± 15*

  1. Data presented as median (SD). *P < 0.05 compared with 0 IU/ml LMWH.
Back to article page

Critical Care

ISSN: 1364-8535